Prospective randomized comparison of high-frequency oscillatory and conventional ventilation in respiratory distress syndrome

R. H. Clark, D. R. Gerstmann, Donald Null, R. A. DeLemos

Research output: Contribution to journalArticle

305 Citations (Scopus)

Abstract

A prospective randomized trial with a crossover design was conducted to compare the efficacy and safety of two distinct strategies of high-frequency oscillatory ventilation (HFOV) to conventional intermittent mandatory ventilation (CV) in the management of respiratory distress syndrome. Only premature neonates with a birth weight less than 1.751 kg were eligible for enrollment into the study. Of 83 patients studied, 26 patients were assigned to CV-only, 27 to HFOV for 72 hours followed by CV (HFOV/CV), and 30 to HFOV- only until extubation. There was no difference among the three groups with respect to the incidence of pulmonary airleak, intraventricular hemorrhage, or death. The highest incidence of chronic lung disease was in the CV-only group. Although both HFOV groups had a lower incidence of chronic lung disease assessed at 30 days and 36 weeks postconception age, the difference was statistically significant only between the CV-only and HFOV-only groups (65% vs 30% at 30 days; P = .008; 38% vs 10% at 36 weeks postconception age, P = .013). These results suggest that use of HFOV as the predominant mode of ventilation in the management of respiratory distress syndrome is as safe as CV and can contribute to a decreased incidence of chronic lung disease. Furthermore, a short (72-hour) period of HFOV support does not provide the same advantage as continuous HFOV.

Original languageEnglish (US)
Pages (from-to)5-12
Number of pages8
JournalPediatrics
Volume89
Issue number1
StatePublished - Jan 1 1992
Externally publishedYes

Fingerprint

High-Frequency Ventilation
Ventilation
Lung Diseases
Chronic Disease
Incidence
Birth Weight
Cross-Over Studies
Newborn Infant
Hemorrhage
Safety
Lung

Keywords

  • bronchopulmonary dysplasia
  • high-frequency oscillatory ventilation
  • hyaline membrane disease

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Prospective randomized comparison of high-frequency oscillatory and conventional ventilation in respiratory distress syndrome. / Clark, R. H.; Gerstmann, D. R.; Null, Donald; DeLemos, R. A.

In: Pediatrics, Vol. 89, No. 1, 01.01.1992, p. 5-12.

Research output: Contribution to journalArticle

@article{e020bdc02a4843c9926b76080464c04e,
title = "Prospective randomized comparison of high-frequency oscillatory and conventional ventilation in respiratory distress syndrome",
abstract = "A prospective randomized trial with a crossover design was conducted to compare the efficacy and safety of two distinct strategies of high-frequency oscillatory ventilation (HFOV) to conventional intermittent mandatory ventilation (CV) in the management of respiratory distress syndrome. Only premature neonates with a birth weight less than 1.751 kg were eligible for enrollment into the study. Of 83 patients studied, 26 patients were assigned to CV-only, 27 to HFOV for 72 hours followed by CV (HFOV/CV), and 30 to HFOV- only until extubation. There was no difference among the three groups with respect to the incidence of pulmonary airleak, intraventricular hemorrhage, or death. The highest incidence of chronic lung disease was in the CV-only group. Although both HFOV groups had a lower incidence of chronic lung disease assessed at 30 days and 36 weeks postconception age, the difference was statistically significant only between the CV-only and HFOV-only groups (65{\%} vs 30{\%} at 30 days; P = .008; 38{\%} vs 10{\%} at 36 weeks postconception age, P = .013). These results suggest that use of HFOV as the predominant mode of ventilation in the management of respiratory distress syndrome is as safe as CV and can contribute to a decreased incidence of chronic lung disease. Furthermore, a short (72-hour) period of HFOV support does not provide the same advantage as continuous HFOV.",
keywords = "bronchopulmonary dysplasia, high-frequency oscillatory ventilation, hyaline membrane disease",
author = "Clark, {R. H.} and Gerstmann, {D. R.} and Donald Null and DeLemos, {R. A.}",
year = "1992",
month = "1",
day = "1",
language = "English (US)",
volume = "89",
pages = "5--12",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "1",

}

TY - JOUR

T1 - Prospective randomized comparison of high-frequency oscillatory and conventional ventilation in respiratory distress syndrome

AU - Clark, R. H.

AU - Gerstmann, D. R.

AU - Null, Donald

AU - DeLemos, R. A.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - A prospective randomized trial with a crossover design was conducted to compare the efficacy and safety of two distinct strategies of high-frequency oscillatory ventilation (HFOV) to conventional intermittent mandatory ventilation (CV) in the management of respiratory distress syndrome. Only premature neonates with a birth weight less than 1.751 kg were eligible for enrollment into the study. Of 83 patients studied, 26 patients were assigned to CV-only, 27 to HFOV for 72 hours followed by CV (HFOV/CV), and 30 to HFOV- only until extubation. There was no difference among the three groups with respect to the incidence of pulmonary airleak, intraventricular hemorrhage, or death. The highest incidence of chronic lung disease was in the CV-only group. Although both HFOV groups had a lower incidence of chronic lung disease assessed at 30 days and 36 weeks postconception age, the difference was statistically significant only between the CV-only and HFOV-only groups (65% vs 30% at 30 days; P = .008; 38% vs 10% at 36 weeks postconception age, P = .013). These results suggest that use of HFOV as the predominant mode of ventilation in the management of respiratory distress syndrome is as safe as CV and can contribute to a decreased incidence of chronic lung disease. Furthermore, a short (72-hour) period of HFOV support does not provide the same advantage as continuous HFOV.

AB - A prospective randomized trial with a crossover design was conducted to compare the efficacy and safety of two distinct strategies of high-frequency oscillatory ventilation (HFOV) to conventional intermittent mandatory ventilation (CV) in the management of respiratory distress syndrome. Only premature neonates with a birth weight less than 1.751 kg were eligible for enrollment into the study. Of 83 patients studied, 26 patients were assigned to CV-only, 27 to HFOV for 72 hours followed by CV (HFOV/CV), and 30 to HFOV- only until extubation. There was no difference among the three groups with respect to the incidence of pulmonary airleak, intraventricular hemorrhage, or death. The highest incidence of chronic lung disease was in the CV-only group. Although both HFOV groups had a lower incidence of chronic lung disease assessed at 30 days and 36 weeks postconception age, the difference was statistically significant only between the CV-only and HFOV-only groups (65% vs 30% at 30 days; P = .008; 38% vs 10% at 36 weeks postconception age, P = .013). These results suggest that use of HFOV as the predominant mode of ventilation in the management of respiratory distress syndrome is as safe as CV and can contribute to a decreased incidence of chronic lung disease. Furthermore, a short (72-hour) period of HFOV support does not provide the same advantage as continuous HFOV.

KW - bronchopulmonary dysplasia

KW - high-frequency oscillatory ventilation

KW - hyaline membrane disease

UR - http://www.scopus.com/inward/record.url?scp=0026580306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026580306&partnerID=8YFLogxK

M3 - Article

C2 - 1728021

AN - SCOPUS:0026580306

VL - 89

SP - 5

EP - 12

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 1

ER -